Wednesday, September 22, 2010

Amen Amedica

The recent acquisition of US Spine by Amedica has raised a few eyebrows to say the least. Rather than be so critical of this move, let's look at the synergies that do and don't exist. Amedica is a company that has positioned itself as developing a new platform in spine and reconstructive surgery with SiN. Silicon Nitride has been around since 1857, when it was first produced by Deville and Wohler ( you have to love the French). It has been used in turbines, car engines and cutting tools. Let's give Amedica the benefit of the doubt that there definitely are inherent and unique qualities in SiN. But the $30 million dollar question is, does this material have the potential to obsolete PEEK? The only way Amedica can substantiate this would be to utilize some of that money to produce a study comparing the clinical efficacy of SiN to PEEK. As TSB has stated before, don't give us the marketing pitch, don't talk about whether you can MRI or shoot CT's, give us the documentation that substantiates that this material improves clinical outcomes, and will improve the patient's quality of life.

The next question that must be answered is whether this is another material breakthrough that is more scientific marketing than substance? Is this really a game changer? Will the market see a company that will expand the use of SiN into coated ceramic pedicle screws? Based on Amedica's press release, the company makes it sound as though they are a bigger player in the spine market than they really are. If this acquisition positions them as a well balanced company, what were they really buying. Another pedicle screw? The opportunity to eliminate their licensing distribution agreement with Integra/Theken Spine for the Tether plate? The facet gun? Could that market be smaller than all the looney toon analysts' predict? Where is the leading edge technology for spine in this acquisition? Even if Amedica can develop a disc out of SiN, what effect will that have on an already cluttered artificial disc market. Will they tout that their disc will be the 5th or 6th generation disc?

In all likelihood, this acquisition was made to position themselves for an IPO, whenever this dogged economy gets back on its feet. This company has talked about IPO since last summer. Based on this acquisition, there isn't enough firepower in the current portfolio to position this for a sale to a legacy company. If anything, the potential of utilizing SiN in total joint implants is where the goose with the golden egg really lies. In closing, if Amedica really wants some credibility, why don't they disclose all the surgeons that are consultants and/or investors in this company? TSB believes that SiN can be a game breaker in recon, but spine? In addition, how much more will they drive up the cost of interbody devices, when there is an all out war in the marketplace surrounding the ASP of this product segment? TSB wants to know what you think.

Monday, September 20, 2010

Is There Anything New and Innovative In Spine?

With the impending Second Annual Spine Technology Awards, its that time again. Albeit, this venue is a step down from San Francisco. There'll be no red carpets. No Hollywood Starlets, it seems Lindsay Lohan will be unavailable by this Friday. TSB wants to know what our readers think is a new and innovative technology? Is there anything new and worthwhile to spend another few hours commiserating with some of the high powered rollers in the industry? Will there be a new emcee, or will we hear the same old same old. For these prices, the least Robin could do is perform a soft shoe. Will Robin kiss Hansen's ring? Genuflect when Hochshuler (aka Hyman Roth) enters the room? Tell us for the 99th time about his good friend Tony V? Who knows maybe Nucky Thompson will make a guest appearance. At least if Nucky appears, he could address the audience like we are all at a temperance meeting. Log on to the OTW website and get your tickets while the last. And remember what Nucky said, "never let the truth get in the way of a good story." TSB wants to know who's in and who's out?

So Who's the Next to Fall?

On September 10th, 2010, TSB published a post entitled, "The Blue Velvets of the Spine Industry." One week later, on September 17th, news hit the street that Applied Spine had retained Gerbsman Partners to solicit interest for the acquisition of all, or substantially all of AST's assets. During the past few weeks, TSB had received a few e-mails from undisclosed sources stating that some employees at AST had already placed their resumes on the street. In addition, to AST, we now hear from a former employee at DMT that this venture is in dire need of capital. With a Clinical Advisory Board made up of fifteen, count that, fifteen of the most prominent names in spine, and a leading PhD, one must wonder if there's trouble in Margaritaville? Supposedly, this operation has already burned through a few million. Anyone not affiliated with this venture must wonder, why a company that has an advisory board made up of the who's who in spine cannot raise the necessary capital to keep this boat afloat? So TSB must ask our readers, if this device is that innovative, why aren't some of these surgeons putting their own money where their mouths are? Have you ever look at this device? One has to wonder, can you insert this device at L5-S1?

On a lighter note, as NASS approaches like a speeding bullet, OTW will be holding its second annual Spine Technology Awards. Where's the entertainment? Oh, TSB forgot, Robin is the entertainment. So the question to our readers is, who will Robin Young be touting this year and whose stock will he be pumping up? Even Mad Money Cramer would be a welcomed sight. Will there be a retrospective on some of the companies that no longer exist? TSB wants to know?

Sunday, September 19, 2010

Sunday Morning Op-Ed Piece

On Friday afternoon, TSB posted a blog about the Jon Stewart and Stephen Colbert parody on the recently held Glen Beck Rally in Washington D.C. Not to anyone's surprise, let alone TSB's, the response that we received was indicative of the class warfare and greed that not only exists today within our country, but also within the industry. As TSB has written in the past, desperate times call for desperate measures. Not only is societal hierarchy changing the country, it has changed our industry. These observations are not based on TSB's beliefs, unlike conservative or liberal talking heads, I have no illusions about where this blog stands in the bigger picture. My concerns lies in the numerous e-mails and conversations that we have with the many people that we communicate with, that are crying out, that like this country, we restore some sanity back to an industry that was once respected, and today is frowned upon. If you don't believe TSB, just look at the industry's latest victim, Applied Spine. So why has this occurred? Let's count the ways.

People talk about how the industry has become "cut throat." The fact is that there is no loyalty either by the corporations that run this industry, nor, the gunslingers that have created a wild, wild, west environment culminating in a now or never mentality. This has been a work in progress. A balance within boundaries is vital to anyone's existence. TSB presumes that non of you that are parents allow your children to run wild, or, that you just don't give them everything that they want. But then, maybe some of you do. Yet, somewhere along the way, everything became short-term. This isn't just TSB's opinion, this is yours, the readers, and the hard working people of this industry. As more companies became entrenched with outside investors, execution, revenue, and profits became short-term concepts. Face it, people that deal in money, have a difficult time grasping time when you can measure and execute a financial transaction in hundreds of seconds. The more promises that are made to the Street, or to PE's, the greater the pressure to produce for R&D, the sales managers, and salespeople, regardless whether these forecasts had any substance behind them to begin with. Just look at the collateral damage, Pegasus, Inion, IST, Archus, etc... Today, the legacy companies are grinding their teeth. Not only are early-growth stage companies taking advantage of this environment, but physicians are branching out into an area that will be legally tested sooner rather than later. The by product is a pre-apocalyptic environment that includes discounted pricing, fly-by night me-too products, physician owned-distributorships, physician owned companies, products that are looking for a clinical indication, illegal consultancies, and an outright attack on sales people by physicians, and vice versa. Even as the Street has lowered guidance for the industry, there are still many companies that have not gotten out of the double digit growth mentality, but they're getting there.

So whether you like Jon Stewart or not, whether you believe in what Glen Beck is selling you, take it down a notch and restore some sanity to your lives. Don't be so angry at the world, you work in an industry that affords you the opportunity to make a great living regardless whether you are making the incision, or selling the product. Take some of that negative energy and turn it into something positive this week and you'll be a happier person. And if you should decide to vote for a candidate that has partaken in Satanic rituals, that is your right as a law abiding American citizen. Don't take yourself so seriously, because in the end, we're nothing more than another brick in the wall, if you weren't, you would be providing solutions to the bigger problem at hand. So today, thank whomever is your god that you're healthy, stop grinding your teeth, smile and have a great day, life is good.


Friday, September 17, 2010

Restore Sanity or Keep Fear Alive You Make the Choice

To Our Fellow Bloggers :

Now is the time to stand up and let your voices be heard. It will bring back the old days at Cal Berkeley or Columbia when people had the gumption to challenge authority and demand that there be some accountability by those that were in power. Well, fellow readers the time has come. On October 30th, Jon Stewart and Stephen Colbert will simultaneously hold rallies in the shadows of the Washington Monument. The Stewart rally is called "The Rally to Restore Sanity," while the Colbert rally is called "The March to Keep Fear Alive." So as Stephen loves to call out every night TSB implores our readers, Nation, its time for the 70-80% of us that have to work for a living and bring some sanity to this world to unite. Book your hotel rooms and make your travel arrangement as soon as possible. TSB will be on site with a live feed. As Howard Beale once screamed in network, now is the time for you to be heard, I'm mad as hell and I'm not going to take it any more. See you there.

God Save Dynamic Stabilization, Is This Technology on Life Support?

The Sex Pistols once wrote a song entitled, God Save The Queen. By the looks of the latest news, we can rename it God Save The Dynamic Stabilization Market. Based on the latest news release it seems that Applied Spine has retained Gerbsman Partners to solicit interest for the acquisition of all, or substantially all of AST's assets. A private based company with origins in New Haven, Connecticut, AST was going to set the standard for dynamic stabilization. The company had been financed with $47 million over three venture rounds. Just like General Custard at the Battle of Little Bighorn , AST views itself as the "last man standing."

Considering that AST has no fusion labeling and no 510(k) it views itself as the first to market with this device in the United States. Hopefully the investors at Oxford, Bioventures, Interwest, DeNovo, Growth Capital and MB Ventures have all learned a lesson about rolling the dice on a technology that had greater odds than Seabiscuit. Just like Seabiscuit, the Stabilimaxx is tired and sore. If anyone is interested in buying this technology and continuing to develop it, it will take a Tom Smith like trainer to reign in the lack of continuity that this company has experienced. From the beginning, this company was doomed. Tom Woods as CEO, the legendary JP Timms as its VP of R&D. Craig Corrance was hired to do whatever it is that he does to get this to the market. Unfortunately, all other so called dynamic stabilization devices are caught under the FDA's 522 order, which gives the FDA the authority to require a manufacturer to conduct post-market surveillance of a Class II or Class III device that meets their criteria.

In addition to all of these challenges, AST has had to deal with a few failures which originally surfaced during the 2008 NASS meeting in Toronto. Maybe the VC's need to learn to talk to some of the real people in the trenches in this industry. The financial analysts and soothsayers that have permeated this industry have done more harm than good. As far back as 2006, there were engineers that had looked at this product that said, "Panjabi or No Panjabi, this product is never going to get to the market." Looks like Gerbsman and Partners is looking for someone to buy the scalp of AST. Is the Dynamic Stabilization Market dead in the water? TSB wants to know what our readers think?

Friday Morning Question for Our Readers

Last night while reading comments on the USS/Amedica (sounds like a battleship) merger, TSB observed a pattern in the spine industry. Whenever a start up or early growth stage company seems to flounder, the blame is immediately deflected on the sales people, or distributors that sell the product. During my tenure in spine and god only knows that I have sat next to a few King Solomon's in my life, never once have I heard an egotistical CEO or Senior Executive Manager admit that maybe they came up with the wrong strategy or platform to execute their business plan.

Example #1: "the problem with USS has always been the agents that sell for them." Has anyone ever wondered that maybe the problem with USS was not the agents but the people that managed and ran the company? How do you recruit a Tier 1 distributor with an incomplete portfolio? Which leads to the next example.

Example #2: "the gun is great, but the rep/Dr must understand how (and I will clean up the grammar) it should be used and when it should be used." So as the inventor of the product, and the company that is distributing the product, isn't the onus on your shoulders to create a comprehensive educational/clinical platform (has anyone learned anything from Synthes or NuVasive) so that the distributor and/or the surgeon can understand how to effectively sell or use your products?

Those comments are a blatant indictment on the incompetence of the people that ran this company. Wasn't Paul Sendro the savior based on his experience with Blackstone and his bio as a USS Board of Director? I guess he learned at Vertebron and USS that you can't make Beef Wellington out of bullshit. But then, would we expect otherwise, considering that we have become a society that shuns accountability, while applauding and rewarding bad behavior (the Christian coalition should love that statement)? One has to wonder, what is a company the size of USS up to when they had fifteen surgeons on their Medical Advisory Board? Just because you have come up with a new pedicle screw design another piece of plastic, or a facet gun doesn't mean your product is an outlier. Nor, does it mean the market for that product is as big as you believe. Many people genuinely feel that just because they invented a product (me too no less), that their baby is beautiful. Unfortunately, the reality is that your baby is just another average child, with average performance grades and SAT scores. Maybe some of these people should get off their fat asses and go out and travel with their distributors, get into surgery and learn something, and listen to the diverse clinical opinions and financial challenges that exist today. How quickly many of us forget that if you started in this business in the 80's and 90's there weren't as many company's and equivalent products that have glutted the market. Until management understands that people are not a commodity, but an asset, and that loyalty means not firing someone that was 100% of quota over the past two years to bring in your friends will this industry ever change.

So TSB wants to know is it US or THEM?